|
|
Volumn 2, Issue 2, 2008, Pages 185-189
|
|
Chronic HBV infection with persistently normal ALT b. not to treat
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADEFOVIR;
ALANINE AMINOTRANSFERASE;
ALPHA INTERFERON;
CLEVUDINE;
ENTECAVIR;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PEGINTERFERON ALPHA;
TELBIVUDINE;
VIRUS DNA;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANTIVIRAL THERAPY;
ARTICLE;
CANCER RISK;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
DRUG COST;
DRUG EFFICACY;
HEPATITIS B;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
PRIORITY JOURNAL;
PROGNOSIS;
SEROCONVERSION;
TREATMENT RESPONSE;
|
|
EID: 51049117119
PISSN: 19360533
EISSN: 19360541
Source Type: Journal
DOI: 10.1007/s12072-008-9068-z Document Type: Article |
|
Times cited : (16)
|
|
References (38)
|
